Development of a Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism in Patients With Cancer-Associated Venous Thromboembolism

Long-term low-molecular-weight heparin (LMWH) is the current standard for treatment of venous thromboembolism (VTE) in cancer patients. Whether treatment strategies should vary according to individual risk of VTE recurrence remains unknown. We performed a retrospective cohort study and a validation...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation (New York, N.Y.) N.Y.), 2012-07, Vol.126 (4), p.448-454
Hauptverfasser:	LOUZADA, Martha L, CARRIER, Marc, WELLS, Philip S, LAZO-LANGNER, Alejandro, DAO, Vi, KOVACS, Michael J, RAMSAY, Timothy O, RODGER, Marc A, ZHANG, Jerry, LEE, Agnes Y. Y, MEYER, Guy
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticoagulants - therapeutic use Biological and medical sciences Blood and lymphatic vessels Blood. Blood coagulation. Reticuloendothelial system Cardiology. Vascular system Cohort Studies Coumarins - therapeutic use Decision Support Techniques Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous Female Heparin, Low-Molecular-Weight - therapeutic use Humans Male Medical sciences Middle Aged Models, Statistical Neoplasms - complications Pharmacology. Drug treatments Proportional Hazards Models Reproducibility of Results Retrospective Studies Risk Assessment Risk Factors Secondary Prevention Sensitivity and Specificity Venous Thromboembolism - epidemiology Venous Thromboembolism - prevention & control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!